drugset / Trial / NCT00515801

Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM

NCT00515801

Phase 2/3 Completed 18 enrolled University Hospital, Basel, Switzerland
RandomizedCrossoverSingle-blindPrevention

Summary

We aim to demonstrate that oral administration of glibenclamide stimulates pancreatic glucagon secretion during hypoglycemia in insulin-deficient (C-peptide negative) patients with type 1 diabetes when compared to type 1 diabetic patients with residual insulin secretion (C-peptide positive).

Timeline

Start
2007-06
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Glyburide Small molecule 15 mg Oral